With an invitation-only in-person audience, and a broader virtual audience, this hybrid meeting brings together a worldwide network of vitreoretinal experts to discuss ongoing clinical trials and the latest data. MCPI has planned this jam-packed one-day meeting since its second annual meeting in 2022.